Literature DB >> 28474248

A potential role for staphylococcal and streptococcal superantigens in driving skewing of TCR Vβ subsets in tonsillar hyperplasia.

Fiona J Radcliff1, Fiona Clow2, Murali Mahadevan3, James Johnston4, Thomas Proft2, Richard G Douglas4, John D Fraser5.   

Abstract

The TCR Vβ repertoire from patients with recurrent tonsillitis and/or tonsillar hyperplasia was examined to determine whether the TCR Vβ composition is suggestive of local superantigen activity and if so, whether it is associated with the presence of superantigen producing bacteria. Tonsil specimens were cultured aerobically to allow identification and isolation of the bacterial pathogens Staphylococcus aureus and Group A Streptococcus. TCR Vβ subset analysis of tonsil leucocytes was performed by flow cytometry. The superantigenic potential of tonsil S. aureus isolates was determined by multiplex PCR and a T-cell mitogenicity assay. Tonsils were collected from 40 patients who were predominantly pre-school-aged children undergoing surgery for either recurrent tonsillitis or tonsillar hyperplasia causing obstructive sleep apnoea. S. aureus was cultured from 23/40 and Group A Streptococcus from 5/40 patients. Both CD4+ and CD8+ TCR Vβ populations were skewed in 17/40 patients. Twelve of these had recurrent tonsillitis of whom 9 also harboured S. aureus. Characterisation of tonsillar S. aureus isolates revealed that many contained genes for one or more potent superantigens and detection of these genes was associated with in vitro mitogenic activity. Skewing of the tonsillar TCR Vβ repertoire was observed at high frequency and was most commonly associated with the presence of S. aureus. Many S. aureus isolates were mitogenic suggesting that they have a potential for local impact on the function of tonsil T cell populations. These results suggest the possibility that anti-staphylococcal antibiotics may be an effective treatment option for some patients.

Entities:  

Keywords:  Staphylococcus aureus; Streptococcus pyogenes; Superantigens; TCR Vβ profiling; Tonsillar hyperplasia

Mesh:

Substances:

Year:  2017        PMID: 28474248     DOI: 10.1007/s00430-017-0510-5

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  28 in total

Review 1.  Beta-lactamase-producing bacteria in mixed infections.

Authors:  I Brook
Journal:  Clin Microbiol Infect       Date:  2004-09       Impact factor: 8.067

2.  The immunology of tonsils in children: the effect of bacterial load on the presence of B- and T-cell subsets.

Authors:  L Brodsky; L Moore; J F Stanievich; P L Ogra
Journal:  Laryngoscope       Date:  1988-01       Impact factor: 3.325

3.  Induction of contact-dependent CD8(+) regulatory T cells through stimulation with staphylococcal and streptococcal superantigens.

Authors:  Amanda L Taylor; Elizabeth L A Cross; Martin J Llewelyn
Journal:  Immunology       Date:  2012-02       Impact factor: 7.397

4.  Intracellular persisting Staphylococcus aureus is the major pathogen in recurrent tonsillitis.

Authors:  Andreas E Zautner; Merit Krause; Gerhard Stropahl; Silva Holtfreter; Hagen Frickmann; Claudia Maletzki; Bernd Kreikemeyer; Hans Wilhelm Pau; Andreas Podbielski
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

5.  Molecular analysis of staphylococcal superantigens.

Authors:  Wilmara Salgado-Pabón; Laura C Case-Cook; Patrick M Schlievert
Journal:  Methods Mol Biol       Date:  2014

6.  egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin.

Authors:  Silva Holtfreter; Kristin Bauer; Damien Thomas; Christine Feig; Vera Lorenz; Katharina Roschack; Erika Friebe; Kathleen Selleng; Sandra Lövenich; Timm Greve; Andreas Greinacher; Brigitte Panzig; Susanne Engelmann; Gérard Lina; Barbara M Bröker
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

7.  Staphylococcus aureus superantigens elicit redundant and extensive human Vbeta patterns.

Authors:  Damien Thomas; Olivier Dauwalder; Virginie Brun; Cedric Badiou; Tristan Ferry; Jerome Etienne; François Vandenesch; Gerard Lina
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

8.  Molecular mapping to species level of the tonsillar crypt microbiota associated with health and recurrent tonsillitis.

Authors:  Anders Jensen; Helena Fagö-Olsen; Christian Hjort Sørensen; Mogens Kilian
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

9.  A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia.

Authors:  Gillian J Wilson; Keun Seok Seo; Robyn A Cartwright; Timothy Connelley; Olivia N Chuang-Smith; Joseph A Merriman; Caitriona M Guinane; Joo Youn Park; Gregory A Bohach; Patrick M Schlievert; W Ivan Morrison; J Ross Fitzgerald
Journal:  PLoS Pathog       Date:  2011-10-13       Impact factor: 6.823

10.  Characterization of a mouse-adapted Staphylococcus aureus strain.

Authors:  Silva Holtfreter; Fiona J Radcliff; Dorothee Grumann; Hannah Read; Sarah Johnson; Stefan Monecke; Stephen Ritchie; Fiona Clow; Christiane Goerke; Barbara M Bröker; John D Fraser; Siouxsie Wiles
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

View more
  3 in total

1.  Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.

Authors:  F J Davies; C Olme; N N Lynskey; C E Turner; S Sriskandan
Journal:  Clin Exp Immunol       Date:  2019-03-13       Impact factor: 4.330

2.  Impact of Superantigen-Producing Bacteria on T Cells from Tonsillar Hyperplasia.

Authors:  Fiona J Radcliff; Sharon Waldvogel-Thurlow; Fiona Clow; Murali Mahadevan; James Johnston; Gen Li; Thomas Proft; Richard G Douglas; John D Fraser
Journal:  Pathogens       Date:  2019-06-27

Review 3.  T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion.

Authors:  Freya R Shepherd; James E McLaren
Journal:  Int J Mol Sci       Date:  2020-08-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.